Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK). Scott H. Watterson , Qingjie Liu , Myra Beaudoin Bertrand , Douglas G. Batt , Ling Li , Mark A. Pattoli , Stacey Skala , Lihong Cheng , Mary T. Obermeier , Robin Moore , Zheng Yang , Rodney Vickery , Paul A. Elzinga , Lorell Discenza , Celia D'Arienzo , Kathleen M. Gillooly , Tracy L. Taylor , Claudine Pulicicchio , Yifan Zhang , Elizabeth Heimrich , Kim W. McIntyre , Qian Ruan , Richard A. Westhouse , Ian M. Catlett , Naiyu Zheng , Charu Chaudhry , Jun Dai , Michael A. Galella , Andrew J. Tebben , Matt Pokross , Jianqing Li , Rulin Zhao , Daniel Smith , Richard Rampulla , Alban Allentoff , Michael A. Wallace , Arvind Mathur , Luisa Salter-Cid , John E. Macor , Percy H. Carter , Aberra Fura , James R. Burke , Joseph A. Tino Journal of Medicinal Chemistry（2019）
AI 理解论文
溯源树
样例
